Acetyl Tetrapeptide-2 and Elastic Fiber Formation: Research on Fibulin-5, LOXL1, and Skin Firmness

1. What Is Acetyl Tetrapeptide-2?

The cosmetic ingredient name of acetyl tetrapeptide-2 is Acetyl Tetrapeptide-2. It is a synthetic short peptide composed of four amino acids and modified by acetylation at the N-terminus. Its commonly cited sequence is Ac–Lys–Asp–Val–Tyr–OH, with the molecular formula C₂₆H₃₉N₅O₉, a relative molecular mass of approximately 565.62, and CAS No. 757942-88-4.

Acetyl tetrapeptide-2 is not a naturally occurring structural fragment of collagen or elastin, nor is it directly incorporated into existing collagen fibers or elastic fibers as a structural component. It is a synthetic functional peptide used in cosmetics. Research on this ingredient has mainly investigated whether it can regulate gene- and protein-related markers associated with extracellular matrix formation.

Current research related to skin-firming effects has primarily focused on four categories of markers: elastin, Fibulin-5, lysyl oxidase-like 1, and type I collagen. The first three are involved in the formation and assembly of elastic fibers, whereas type I collagen is associated with the tensile strength and structural support of the dermis.

2. Why Is Acetyl Tetrapeptide-2 Associated with Skin Firmness?

2.1 Skin Firmness Depends on the Structure and Function of the Extracellular Matrix

The extracellular matrix, or ECM, is the three-dimensional supporting structure surrounding dermal cells. It is mainly composed of collagen fibers, elastic fibers, glycoproteins, proteoglycans, and a variety of regulatory proteins.

Type I collagen is the principal fibrillar collagen in the dermis and is responsible for resisting tensile forces and maintaining tissue strength. Elastic fibers can stretch under mechanical force and return to their original shape after the force is removed. These two fiber systems perform different mechanical functions and together influence skin firmness and resilience.

The formation of functional fibers from intracellularly synthesized structural proteins involves three consecutive stages:

1. Synthesis and secretion: Fibroblasts produce and release type I collagen precursors and tropoelastin.

2. Localization and assembly: After secretion, these proteins are deposited and arranged in the extracellular space to form organized structures.

3. Cross-linking and maturation: Stable connections form between adjacent protein molecules, enabling the fibers to acquire tensile strength or elastic recoil.

For elastic fibers, simply increasing tropoelastin is not sufficient. Tropoelastin must also be deposited onto a microfibrillar scaffold and undergo organized assembly and cross-linking with the involvement of proteins such as Fibulin-5 and LOXL1 before a stable elastic structure can be formed.

2.2 Structural Processes Examined in Existing Studies

In vitro studies related to acetyl tetrapeptide-2 have examined the following three categories of markers:

Research marker	Corresponding structural significance
Soluble elastin measured using the Fastin assay	Reflects the amount of soluble elastin detected after extraction and dye-binding analysis
Fibulin-5- and LOXL1-related markers	Respectively associated with tropoelastin organization and localization, and with cross-linking reactions
Type I collagen	Associated with the tensile strength and structural support of the dermis

These markers provide a biological basis for associating acetyl tetrapeptide-2 with skin firmness. The peptide may affect not only the production of structural proteins but also the assembly-related proteins required for elastic fiber formation.

Current studies indicate changes in markers related to gene regulation and protein detection. No direct receptor for acetyl tetrapeptide-2 has been identified in publicly available peer-reviewed research, and there is no evidence that it directly binds to Fibulin-5 or directly increases the enzymatic activity of LOXL1.

3. How Are Elastic Fibers Formed?

Mature elastic fibers consist of a cross-linked elastin core surrounded by microfibrils. The formation of elastic fibers with functional recoil properties involves several processes, including the production of structural precursors, deposition onto a scaffold, spatial organization, and molecular cross-linking.

3.1 Tropoelastin Provides the Structural Precursor

Based on the genetic information encoded by the elastin gene, fibroblasts synthesize and secrete tropoelastin. Tropoelastin is a soluble monomeric precursor. After entering the extracellular space, it undergoes coacervation, bringing multiple molecules into close proximity and creating conditions favorable for subsequent deposition and cross-linking.

At this stage, an increase represents an increase in the precursor material required for elastic fiber formation. It does not mean that mature elastic fibers have already been formed.

3.2 Microfibrils Provide a Scaffold for Deposition

Microfibrils, which are primarily composed of fibrillin-1, provide sites and directional guidance for tropoelastin deposition. Tropoelastin must aggregate in an organized manner around the microfibrils before a continuous elastic structure can develop.

Elastic fiber formation must address two questions simultaneously:

1. Where should tropoelastin be deposited?

2. How should adjacent tropoelastin molecules form stable connections?

FBLN5 and LOXL1 are involved in these two key processes.

3.3 FBLN5 Organizes Tropoelastin Localization and Assembly

FBLN5 is the gene name, and its encoded protein is Fibulin-5. Fibulin-5 is a secreted extracellular matrix glycoprotein that can interact with tropoelastin, fibrillin-containing microfibrils, cell-surface integrins, and certain members of the lysyl oxidase family.

After Fibulin-5 is deposited on microfibrils, it helps tropoelastin aggregate and align at appropriate sites. It may also help cross-linking enzymes such as LOXL1 approach areas of elastin deposition. Therefore, Fibulin-5 mainly participates in the organization and localization of tropoelastin, microfibrils, and cross-linking enzymes rather than directly forming part of the elastin core.

Mice deficient in FBLN5 exhibit severe systemic disruption of elastic fibers, accompanied by loose skin, emphysema, and abnormal vascular compliance. These findings indicate that Fibulin-5 is an important protein required for the normal organization of elastic fibers.

3.4 LOXL1 Participates in the Initial Reactions of Intermolecular Elastin Cross-Linking

Lysyl oxidase-like 1, or LOXL1, is a copper-dependent enzyme and an important member of the lysyl oxidase family involved in elastin maturation and cross-linking.

Its function can be understood in two stages.

Stage 1: Conversion of Lysine to Allysine

Tropoelastin contains multiple lysine residues. LOXL1 catalyzes the oxidative deamination of some of these lysine residues, converting them into the more reactive aldehyde derivative allysine.

Copper is a cofactor required for LOXL1 to maintain its normal enzymatic structure and catalytic function. It is not a formulation ingredient that independently participates in elastin cross-linking.

Stage 2: Formation of Stable Connections Between Elastin Molecules

After allysine is generated, it can undergo condensation reactions with adjacent lysine residues or other allysine residues, creating covalent connections between different tropoelastin molecules. As multiple cross-linking reactions proceed, elastin-specific cross-linking structures such as desmosine and isodesmosine can form.

Lysine

↓ LOXL1-catalyzed reaction

Allysine

↓ Condensation with adjacent residues

Covalent cross-links form between elastin molecules

↓

Formation of a stable, insoluble elastin network with elastic recoil properties

LOXL1 initiates the oxidative reaction required for cross-linking, but it does not independently catalyze all subsequent condensation steps. In mice lacking LOXL1, tropoelastin may accumulate, but mature elastic fibers are not deposited normally. These animals may also develop loose skin, enlarged alveoli, and pelvic organ prolapse.

3.5 The Complete Process of Elastic Fiber Formation

Tropoelastin synthesis and secretion → Extracellular coacervation of tropoelastin → Deposition onto the fibrillin-containing microfibrillar scaffold → Fibulin-5 organizes tropoelastin, microfibrils, and cross-linking enzymes → LOXL1 converts selected lysine residues into allysine → Covalent cross-links form between elastin molecules → Mature elastic fibers are formed

This sequence demonstrates that an “increase in measured elastin” and an “increase in mature elastic fibers” are two different experimental findings. The formation of mature elastic fibers also requires correct deposition, normal LOXL1 enzymatic activity, and complete intermolecular cross-linking.

4. Acetyl Tetrapeptide-2 and Elastic Fiber Formation: Biological Relevance and In Vitro Evidence

Elastic fiber formation requires the coordinated action of structural precursors, spatial organization, and molecular cross-linking. Tropoelastin provides the protein basis for elastic fiber formation. Fibulin-5 helps tropoelastin aggregate and localize around microfibrils, while lysyl oxidase-like 1 catalyzes lysine oxidation and creates the conditions required for the subsequent formation of stable intermolecular cross-links.

The main publicly available data concerning the effects of acetyl tetrapeptide-2 on these processes are derived from the UPLEVITY™ peptide solution technical report published by Lipotec. In cultured human dermal fibroblasts, the report examined extractable elastin, Fibulin-5, lysyl oxidase-like 1, type I collagen, and related markers.

In vitro marker	Reported result	Relationship to skin structure
Soluble elastin measured using the Fastin assay	Increased by 21.7%	Indicates an increase in the measured level of soluble elastin in the culture system; this result is not equivalent to increased elastin cross-linking or mature elastic fiber formation
Fibulin-5 protein signal	Approximately 2.3-fold compared with the control	Fibulin-5 participates in the aggregation, localization, and organization of tropoelastin around microfibrils
Lysyl oxidase-like 1 protein signal	Approximately 1.7-fold compared with the control	This protein is involved in lysine oxidation and the initial stages of elastin cross-linking
Type I collagen	Increased by 47.3%	Indicates an increase in measured type I collagen in the culture medium and is associated with dermal tensile strength and structural support

The first three findings respectively involve measured soluble elastin, an elastic fiber assembly-related protein, and the protein signal of a cross-linking-related enzyme. These markers are biologically connected along the elastic fiber formation pathway.

The data indicate that after treatment with acetyl tetrapeptide-2, not only did elastin-related measurements increase, but protein signals associated with tropoelastin localization and cross-linking also increased.

These experiments measured protein content or immunofluorescence signals in cultured systems. They did not directly measure the catalytic activity of lysyl oxidase-like 1, elastin-specific cross-linking products, or the number of mature elastic fibers.

Therefore, the available in vitro findings support the possibility that acetyl tetrapeptide-2 may influence several processes associated with elastic fiber formation, but they do not demonstrate that the amount of mature elastic fibers has increased.

Type I collagen represents a separate experimental finding related to dermal support and does not participate in the Fibulin-5–lysyl oxidase-like 1 assembly pathway of elastic fibers. The increase in its measured level suggests that acetyl tetrapeptide-2 may also affect collagen-related metabolism. However, because this result was obtained from an in vitro fibroblast experiment, it cannot be directly extrapolated to an increase in type I collagen in the human dermis after topical application.

5. Have Human Studies Observed Changes Related to Skin Firmness?

Human efficacy data for acetyl tetrapeptide-2 are mainly derived from the UPLEVITY™ peptide solution technical report published by Lipotec. The available studies evaluated dermal fiber imaging parameters and skin biomechanical parameters, but did not directly measure FBLN5, LOXL1, type I collagen, or mature elastic fiber content in human skin.

Study design	Main results	What the findings indicate
A split-face controlled study involving 19 women aged 50–60 years. A vehicle-control emulsion was applied to one side of the face, while an emulsion containing 2% of the commercial ingredient was applied to the other side twice daily for 55 days.	The reported fiber-fragmentation rates in the shallower and deeper dermal layers decreased by 39.6% and 37.9%, respectively, on the active-formulation side. On the control side, the values decreased by 0.8% and increased by 12.7%, respectively.	On the side treated with the commercial ingredient containing acetyl tetrapeptide-2, the dermal fiber-network imaging parameters defined in the report were more favorable than those on the vehicle-control side.
Forty women aged 40–60 years were assigned to groups using formulations containing 1% or 2% of the commercial ingredient. The products were applied twice daily for 56 days.	In the 1% group, maximum deformation decreased by 20.3% and overall elasticity increased by 10.9%. In the 2% group, the corresponding changes were a 25.2% decrease and a 16.0% increase.	Changes in skin biomechanical parameters were observed after use of both formulations. However, because no vehicle-control group was included, the independent contribution of acetyl tetrapeptide-2 cannot be determined.

The split-face study used reflectance confocal microscopy to examine images of skin tissue. This method can assess fiber-network morphology at defined depths, but it cannot directly distinguish type I collagen from elastic fibers and cannot confirm the formation of new mature elastic fibers.

Skin biomechanical testing reflects the degree of deformation and recovery of the skin after mechanical loading. In the report, changes in the 2% group were greater than those in the 1% group. However, the study did not include a vehicle control without the active ingredient and did not provide sufficient between-group dose–response validation. Therefore, the observed changes cannot be attributed entirely to acetyl tetrapeptide-2.

The 1% and 2% concentrations in the report refer to the amount of the commercial UPLEVITY™ peptide solution added to the final formulation, not to the concentration of pure acetyl tetrapeptide-2.

Taken together, the two studies indicate that formulations containing the commercial acetyl tetrapeptide-2 ingredient were associated with improvements in dermal imaging parameters and skin biomechanical parameters in small study populations. However, the human studies did not directly demonstrate increased expression of FBLN5 or LOXL1, or increased levels of mature elastic fibers or type I collagen.

6. What Can the Existing Evidence Demonstrate?

The currently available evidence can be divided into three levels: fundamental biological research, in vitro studies of acetyl tetrapeptide-2, and human formulation studies. These three categories are related, but they address different questions.

Fundamental research has established the roles of Fibulin-5 and lysyl oxidase-like 1, or LOXL1, in elastic fiber formation. Fibulin-5 participates in the aggregation, localization, and organization of tropoelastin around microfibrils. LOXL1 catalyzes lysine oxidation, creating the conditions required for stable cross-links to form between elastin molecules. Deficiency or dysfunction of these proteins can lead to impaired elastic fiber deposition and tissue laxity.

The UPLEVITY™ peptide solution technical report published by Lipotec indicates that treatment with acetyl tetrapeptide-2 increased measured levels or signals associated with Fibulin-5, LOXL1, extractable elastin, and type I collagen in cultured cells. Small human studies also reported improvements in certain dermal fiber imaging parameters and skin biomechanical parameters after the use of formulations containing the commercial ingredient.

These findings suggest that acetyl tetrapeptide-2 treatment is associated with increases in elastin-related materials, proteins involved in elastic fiber assembly, and type I collagen measurements. They also provide preliminary experimental support for its use in firming skincare formulations.

However, fundamental research demonstrating the biological functions of Fibulin-5 and LOXL1 does not mean that acetyl tetrapeptide-2 has been proven to rebuild human elastic fibers through these two proteins.

Three key questions remain unresolved:

1. Whether a sufficient amount of structurally intact acetyl tetrapeptide-2 can penetrate the skin barrier and reach the dermis after topical application.

2. Whether Fibulin-5 is correctly deposited and participates in elastic fiber assembly, whether LOXL1 catalytic activity is increased, and whether these changes ultimately increase elastin cross-linking and the formation of mature elastic fibers.

3. Whether the currently reported human findings can be reproduced in independent, large-sample, randomized, double-blind, vehicle-controlled studies.

7. Representative Chemicals and Research Applications Related to Acetyl Tetrapeptide-2, FBLN5/LOXL1, and Elastic Fiber Formation

Table 1. Constituent Amino Acids and Protected Amino Acids for Acetyl Tetrapeptide-2

Category	CAS No.	Aladdin Cat. No.	Product Name	Grade or Purity	Product Features and Applications
Constituent amino acid	56-87-1	L598932	L-Lysine	Moligand™, ≥98%, metals <500 ppm	The N-terminal amino acid constituent of the acetyl tetrapeptide-2 sequence; used in peptide synthesis, amino acid composition analysis, and raw-material quality studies.
Constituent amino acid	56-84-8	L476204	L-Aspartic acid	UltraBio™, ultrapure grade, ≥99.5% (T)	The second amino acid constituent of the acetyl tetrapeptide-2 sequence; used in peptide synthesis, amino acid composition analysis, and related control studies.
Constituent amino acid	72-18-4	L755656	L-Valine	UltraBio™, ≥99.5% (NT)	The third amino acid constituent of the acetyl tetrapeptide-2 sequence; used in peptide synthesis, sequence composition analysis, and raw-material quality control.
Constituent amino acid	60-18-4	T1521620	L-Tyrosine	Animal-origin-free, ≥99%, fermentation-derived	The C-terminal amino acid constituent of the acetyl tetrapeptide-2 sequence; used in peptide synthesis, amino acid composition analysis, and raw-material quality studies.
Protected amino acid	71989-26-9	F110978	Nα-(9-Fluorenylmethoxycarbonyl)-Nε-tert-butoxycarbonyl-L-lysine, Fmoc-Lys(Boc)-OH	≥98%	A lysine derivative in which the main-chain α-amino group is protected with Fmoc and the side-chain ε-amino group is protected with Boc; used for introducing lysine residues and constructing peptide chains in solid-phase peptide synthesis.
Protected amino acid	71989-14-5	F116773	Fmoc-L-aspartic acid β-tert-butyl ester	≥98%	An aspartic acid derivative with a protected side-chain carboxyl group; used to introduce aspartic acid residues in solid-phase peptide synthesis while controlling side-chain reactions.
Protected amino acid	68858-20-8	F100805	Fmoc-L-valine	≥98%	An amino-protected valine derivative used for introducing valine residues and carrying out stepwise peptide-chain elongation in solid-phase peptide synthesis.
Protected amino acid	71989-38-3	F116803	Fmoc-O-tert-butyl-L-tyrosine	≥98%	A tyrosine derivative with a protected phenolic hydroxyl group; used to introduce the C-terminal tyrosine residue in solid-phase peptide synthesis while preventing side reactions involving the phenolic hydroxyl group.

Table 2. Reagents for Peptide-Chain Assembly and N-Terminal Acetylation

Category	CAS No.	Aladdin Cat. No.	Product Name	Grade or Purity	Product Features and Applications
Peptide coupling reagent	148893-10-1	H109327	O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate (HATU)	≥99%	Used for carboxyl-group activation and peptide-bond formation; applicable to acetyl tetrapeptide-2 sequence assembly, coupling-efficiency evaluation, and optimization of synthesis conditions.
Auxiliary coupling base	7087-68-5	D109322	N,N-Diisopropylethylamine	Distilled grade, ≥99.5%	A non-nucleophilic organic base used to neutralize acids generated during coupling reactions, maintain alkaline reaction conditions, and promote peptide-bond formation.
Deprotection reagent	110-89-4	P1506346	Piperidine (regulated precursor chemical)	Biotechnology grade, ≥99.5%	Used for Fmoc deprotection in solid-phase peptide synthesis, exposing the peptide-chain amino group for the next coupling reaction.
N-terminal acetylation reagent	108-24-7	A1506320	Acetic anhydride (regulated precursor chemical)	European Pharmacopoeia (Ph. Eur.), puriss. p.a., ISO, ACS, ≥99% (GC)	Used for N-terminal acetylation of synthetic peptides and capping of unreacted amino groups; applicable to terminal modification, synthesis-process studies, and purity-control research involving acetyl tetrapeptide-2.

Table 3. Research Materials for Collagen, Elastin, and Lysyl Oxidase-Mediated Cross-Linking

Category	CAS No.	Aladdin Cat. No.	Product Name	Grade or Purity	Product Features and Applications
Reagent for copper-dependent enzyme research	7758-99-8	C112411	Copper sulfate pentahydrate	For cell culture, ≥98%	Serves as a controlled source of copper ions in cell-culture systems and is used to investigate the effects of copper status on lysyl oxidase-family protein maturation, enzymatic activity, and collagen and elastin cross-linking.
Lysyl oxidase-family inhibitor	151-18-8	A107499	3-Aminopropionitrile (BAPN)	Moligand™, ≥98%, stabilized with 0.1% potassium carbonate	Used to inhibit lysyl oxidase-family activity, verify the dependence of collagen and elastin cross-linking on enzymatic activity, and establish models of inhibited extracellular-matrix cross-linking.
Marker for collagen analysis	51-35-4	H111005	L-Hydroxyproline	Moligand™, ≥99%	A characteristic amino acid found in collagen; used as a standard for quantifying collagen hydrolysates, studying collagen synthesis and degradation, and developing analytical methods.
Elastin research material	9007-58-3	E754127	Porcine elastin	≥90%	Used in elastin content analysis, enzymatic degradation studies, cross-linking-structure research, material-performance evaluation, and in vitro experiments related to elastic fibers.
Marker of elastin cross-linking	991-01-5	I1019013	Isodesmosine	_	A characteristic cross-linking amino acid in mature elastin; used for quantifying elastin cross-linking products, investigating elastic-fiber degradation and turnover, and developing chromatographic and mass-spectrometric analytical methods.

Note: The products listed above are representative Aladdin products related to scientific research and formulation studies. Additional information on product specifications, grades, and certificates of analysis may be retrieved from the Aladdin website using the product name, CAS number, or catalog number.

References

[1] National Center for Biotechnology Information. PubChem Compound Summary for CID 91936905: Acetyl tetrapeptide-2[DB/OL]. Bethesda (MD): National Library of Medicine (US).

[2] Lipotec. UPLEVITY™ peptide: Technical Report[R]. Revision 3. Gavà, Barcelona: Lipotec; 2015.

[3] Nakamura T, Lozano PR, Ikeda Y, et al. Fibulin-5/DANCE is essential for elastogenesis in vivo[J]. Nature, 2002, 415(6868): 171-175. doi:10.1038/415171a.

[4] Hirai M, Ohbayashi T, Horiguchi M, et al. Fibulin-5/DANCE has an elastogenic organizer activity that is abrogated by proteolytic cleavage in vivo[J]. Journal of Cell Biology, 2007, 176(7): 1061-1071. doi:10.1083/jcb.200611026.

[5] Liu X, Zhao Y, Gao J, et al. Elastic fiber homeostasis requires lysyl oxidase-like 1 protein[J]. Nature Genetics, 2004, 36(2): 178-182. doi:10.1038/ng1297.

[6] Kagan HM, Li W. Lysyl oxidase: properties, specificity, and biological roles inside and outside of the cell[J]. Journal of Cellular Biochemistry, 2003, 88(4): 660-672. doi:10.1002/jcb.10413.

[7] Kielty CM, Sherratt MJ, Shuttleworth CA. Elastic fibres[J]. Journal of Cell Science, 2002, 115(14): 2817-2828. doi:10.1242/jcs.115.14.2817.

For more related articles, see below:

Applicability Comparison of Vitronectin, Laminin and Fibronectin in Cell Culture Coating Systems

Antibody simulation experiments based on the framework of fibronectin type III structural domains

Cosmetic Peptides

Resveratrol

Ferulic Acid: Structural Features, Preparation Routes, and Key Points for Research Applications

Role of Sphingolipid Metabolic Remodeling in Apoptotic and Inflammatory Signaling

Cosmetic Grade Explained

How to decipher the whitening code?

Niacin (Vitamin B3): Structural Features, Metabolic Roles, and Application Landscape

The "Six Key Checkpoints" of Skin Lightening

Tyrosinase: a key regulatory enzyme in melanin synthesis and its biological and applied significance

Glutathione (GSH) Quantification: Method Systems, Experimental Workflows, and Key Quality-Control Considerations

Glutathione Reductase: A Flavin-Dependent Reductive System Maintaining GSH/GSSG Homeostasis, with Assays and Applications

What is Glutathione？

What Is Glutathione Agarose?

Enzymatic Hydroxylation Mechanism of Salicylate Conversion to Catechol